Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

H. Schelleman; O.H. Klungel; J.C.M. Witteman; M.M.B. Breteler; A. Hofman; C.M. van Duijn; A. de Boer; B.H.Ch. Stricker

Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

H. Schelleman
, O.H. Klungel
, J.C.M. Witteman
, M.M.B. Breteler
, A. Hofman
, C.M. van Duijn
, A. de Boer
, B.H.Ch. Stricker

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	22-26
Number of pages	5
Journal	The Pharmacogenomics Journal
Volume	6
Issue number	1
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

@article{f2a6026948f84160a32221ab2da99e07,

title = "Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "H. Schelleman and O.H. Klungel and J.C.M. Witteman and M.M.B. Breteler and A. Hofman and \{van Duijn\}, C.M. and \{de Boer\}, A. and B.H.Ch. Stricker",

year = "2008",

language = "Undefined/Unknown",

volume = "6",

pages = "22--26",

journal = "The Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer Nature",

number = "1",

}

Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke. / Schelleman, H.; Klungel, O.H.; Witteman, J.C.M. et al.
In: The Pharmacogenomics Journal, Vol. 6, No. 1, 2008, p. 22-26.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

AU - Schelleman, H.

AU - Klungel, O.H.

AU - Witteman, J.C.M.

AU - Breteler, M.M.B.

AU - Hofman, A.

AU - van Duijn, C.M.

AU - de Boer, A.

AU - Stricker, B.H.Ch.

PY - 2008

Y1 - 2008

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1470-269X

VL - 6

SP - 22

EP - 26

JO - The Pharmacogenomics Journal

JF - The Pharmacogenomics Journal

IS - 1

ER -